Chongqing Taiji Industry(Group) Co.,Ltd (SHA: 600129)

Market Cap	12.47B
Revenue (ttm)	14.39B
Net Income (ttm)	751.39M
Shares Out	556.89M
EPS (ttm)	1.35
PE Ratio	16.64
Forward PE	12.01
Dividend	0.30 (1.34%)
Ex-Dividend Date	Jun 7, 2024

Volume	7,826,886
Open	22.85
Previous Close	23.01
Day's Range	22.34 - 23.10
52-Week Range	21.04 - 52.10
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Chongqing Taiji Industry(Group) Co.,Ltd

Chongqing Taiji Industry(Group) Co.,Ltd produces and sells Chinese patent medicines, western medicines, Chinese herbal medicines, and other products in China. It offers its products in various areas, such as digestive system and metabolism, respiratory system, cardiovascular and cerebrovascular, systemic anti-infective drugs, endocrine system drugs, nervous system drugs, general health products, etc. The company was incorporated in 1979 and is headquartered in Chongqing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1979
• Employees: 12,589
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600129

Financial Performance

In 2023, 600129's revenue was 15.62 billion, an increase of 10.58% compared to the previous year's 14.13 billion. Earnings were 822.12 million, an increase of 131.99%.